Mycomedica Life Sciences Pbc

This early-stage study tested multiple doses of MLS101, a low-dose psilocybin drug, in 20 healthy adults aged 18 to 55. Researchers used brain scans (fMRI) to see how the drug affects brain activity and checked for side effects and how the drug moves through the body. The goal wa…